FDA and Social Media: The Impact of Social Media on Prescription Drug Advertising

DSpace/Manakin Repository

FDA and Social Media: The Impact of Social Media on Prescription Drug Advertising

Show simple item record

dc.contributor.advisor Peter Hutt en_US
dc.contributor.author Liu, Kassity Yefei
dc.date.accessioned 2012-05-19T22:01:59Z
dc.date.issued 2011
dc.identifier.citation Kassity Yefei Liu, FDA and Social Media: The Impact of Social Media on Prescription Drug Advertising (September 2011). en_US
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8789614
dc.description.abstract The U.S. Food and Drug Administration (FDA) regulates the promotion of prescription drugs. With the emergence of Web 2.0 technology and social media, the FDA faces new regulatory challenges as pharmaceutical companies have started to use social media tools to market prescription drugs to consumers. This paper first explores the history of social media, its use by the FDA, and its growing use by the pharmaceutical industry. The paper then discusses some of the actions that the agency has taken to respond to the industry’s use of social media. Lastly, the paper takes a look at the FDA’s repeated delays in issuing social media guidance, and discusses some of the “social media guidance” that pharmaceutical companies have received from other individuals and groups. en_US
dash.license LAA
dc.subject human drugs>>prescription drug promotion>>physician advertising en_US
dc.subject.other Food and Drug Law en_US
dc.title FDA and Social Media: The Impact of Social Media on Prescription Drug Advertising en_US
dc.type Paper (for course/seminar/workshop) en_US
dash.depositing.author Liu, Kassity Yefei
dc.date.available 2012-05-19T22:01:59Z

Files in this item

Files Size Format View
Liu, Kassity Final Paper_FDA and Social Media.pdf 210.3Kb PDF View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters